Recent News for SRZN - Surrozen, Inc.

Date Title
Jun 4 Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis
Back to the Main SRZN Page...